• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英格兰非创伤性主要下肢截肢的地区差异:基于初级和二级医疗数据关联的观察性研究

Regional variation in non-traumatic major lower limb amputation in England: observational study of linked primary and secondary care data.

作者信息

Meffen Anna, Rutherford Mark J, Sayers Rob D, Houghton John S M, Bradbury Naomi, Gray Laura J

机构信息

Department of Population Health Sciences, University of Leicester, Leicester, UK.

National Institute for Health and Care Research Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.

出版信息

BJS Open. 2025 Mar 4;9(2). doi: 10.1093/bjsopen/zraf004.

DOI:10.1093/bjsopen/zraf004
PMID:40137559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11938355/
Abstract

BACKGROUND

Peripheral artery disease and diabetes are the main primary risk factors for non-traumatic major lower limb amputation. Regional variation in incidence of major lower limb amputation has yet to be fully described in terms of these risk factors and explained. The aim of this study was to estimate yearly incidence of major lower limb amputation over a 10-year interval (2010-2019) across England, by related condition and by region and, additionally, to investigate reasons for regional variation.

METHODS

This observational study utilized primary care (Clinical Practice Research Datalink Aurum), secondary care (Hospital Episode Statistics), death and demographic data in England. Adults registered with a practice using Clinical Practice Research Datalink Aurum and with Hospital Episode Statistics linkage were included. Patients with a record of major lower limb amputation during the interval 1 January 2010 to 31 December 2019 were identified and yearly incidence rates of major lower limb amputation were calculated. Co-morbidities analysed were cardiovascular disease (including coronary artery disease, peripheral artery disease and cerebrovascular disease), diabetes (of any type) and cancer. Demographic and socioeconomic covariates analysed were age, sex, ethnicity, deprivation level, region and urban/rural categorization.

RESULTS

The study included 18 397 483 individuals, 8584 of which had a record of major lower limb amputation. The age-standardized yearly incidence rate of major lower limb amputation in England decreased by 30% from 11.2 per 100 000 person-years in 2010 to 7.8 in 2019. The incidence rate in those with diabetes fell by 30% over the 10-year interval, rose by 20% for those with both diabetes and cardiovascular disease, and changed little in those with cardiovascular disease. In 2019, the age-standardized incidence rate was highest in the North East (14.8 per 100 000 person-years) and lowest in the East of England (4.5 per 100 000 person-years). Between 2010 and 1019, incidence rates decreased across all regions, the largest decrease of 56% in the East Midlands and the smallest of 8% in the North East. Statistically significant regional variation remained after full adjustment for demographic, socioeconomic data and related conditions.

CONCLUSION

Whilst the incidence of major lower limb amputation is decreasing overall, significant regional variation in major lower limb amputation exists and is unexplained by demographic, socioeconomic and health data. Regional differences in service provision and accessibility should be investigated to provide further explanation.

摘要

背景

外周动脉疾病和糖尿病是非创伤性主要下肢截肢的主要原发性危险因素。主要下肢截肢发病率的区域差异尚未根据这些危险因素得到充分描述和解释。本研究的目的是估计2010年至2019年这10年间英格兰主要下肢截肢的年发病率,按相关疾病和地区进行分类,此外,还调查区域差异的原因。

方法

这项观察性研究利用了英格兰的初级医疗(临床实践研究数据链奥鲁姆)、二级医疗(医院事件统计)、死亡和人口数据。纳入了在使用临床实践研究数据链奥鲁姆的医疗机构注册且与医院事件统计有链接的成年人。确定了2010年1月1日至2019年12月31日期间有主要下肢截肢记录的患者,并计算了主要下肢截肢的年发病率。分析的合并症包括心血管疾病(包括冠状动脉疾病、外周动脉疾病和脑血管疾病)、糖尿病(任何类型)和癌症。分析的人口统计学和社会经济协变量包括年龄、性别、种族、贫困水平地区和城乡分类。

结果

该研究纳入了18397483人,其中8584人有主要下肢截肢记录。英格兰主要下肢截肢的年龄标准化年发病率从2010年的每10万人年11.2例下降了30%,至2019年的7.8例。糖尿病患者的发病率在10年期间下降了30%,糖尿病和心血管疾病患者的发病率上升了20%,心血管疾病患者的发病率变化不大。2019年,年龄标准化发病率在东北部最高(每10万人年14.8例),在英格兰东部最低(每10万人年4.5例)。2010年至2019年期间,所有地区的发病率均下降,东米德兰兹降幅最大,为56%,东北部降幅最小,为8%。在对人口统计学、社会经济数据和相关疾病进行全面调整后,仍存在统计学上显著的区域差异。

结论

虽然主要下肢截肢的发病率总体上在下降,但主要下肢截肢存在显著的区域差异,且人口统计学、社会经济和健康数据无法解释这种差异。应调查服务提供和可及性方面的区域差异,以提供进一步解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb4/11938355/758a28c9f2d6/zraf004f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb4/11938355/4d9b67a8c13f/zraf004f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb4/11938355/33690c7e7de0/zraf004f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb4/11938355/bad77513475f/zraf004f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb4/11938355/758a28c9f2d6/zraf004f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb4/11938355/4d9b67a8c13f/zraf004f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb4/11938355/33690c7e7de0/zraf004f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb4/11938355/bad77513475f/zraf004f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb4/11938355/758a28c9f2d6/zraf004f4.jpg

相似文献

1
Regional variation in non-traumatic major lower limb amputation in England: observational study of linked primary and secondary care data.英格兰非创伤性主要下肢截肢的地区差异:基于初级和二级医疗数据关联的观察性研究
BJS Open. 2025 Mar 4;9(2). doi: 10.1093/bjsopen/zraf004.
2
Female patients have fewer limb amputations compared to male patients in the BEST-CLI trial.在BEST-CLI试验中,女性患者的肢体截肢情况比男性患者少。
J Vasc Surg. 2025 Feb;81(2):366-373.e1. doi: 10.1016/j.jvs.2024.09.031. Epub 2024 Oct 4.
3
Risk factors contributing to 30-day and 1-year mortality event scores following major lower extremity amputation for limb ischemia.肢体缺血性疾病行主要下肢截肢术后30天和1年死亡事件评分的危险因素。
J Vasc Surg. 2025 Jul;82(1):216-228.e1. doi: 10.1016/j.jvs.2025.02.030. Epub 2025 Mar 5.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Infusion techniques for peripheral arterial thrombolysis.外周动脉溶栓的输注技术。
Cochrane Database Syst Rev. 2021 Nov 17;11(11):CD000985. doi: 10.1002/14651858.CD000985.pub3.
7
Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.腰交感神经切除术与前列腺素类药物治疗因不可重建的外周动脉疾病导致的严重肢体缺血的比较
Cochrane Database Syst Rev. 2018 Apr 16;4(4):CD009366. doi: 10.1002/14651858.CD009366.pub2.
8
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
9
Bypass surgery for chronic lower limb ischaemia.慢性下肢缺血的搭桥手术。
Cochrane Database Syst Rev. 2017 Apr 3;4(4):CD002000. doi: 10.1002/14651858.CD002000.pub3.
10
Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or diabetes.周围动脉疾病或糖尿病导致的胫骨截肢患者的运动康复干预措施。
Cochrane Database Syst Rev. 2023 Jun 5;6(6):CD013711. doi: 10.1002/14651858.CD013711.pub2.

本文引用的文献

1
Streamlined Clinical Management Pathways May Reduce Major Amputations in Patients with Chronic Limb Threatening Ischaemia: A Prospective Cohort Study with Historical Controls.简化的临床管理路径可能减少慢性肢体威胁性缺血患者的大截肢:一项有历史对照的前瞻性队列研究。
Eur J Vasc Endovasc Surg. 2025 Mar;69(3):465-473. doi: 10.1016/j.ejvs.2024.09.005. Epub 2024 Sep 10.
2
Documentary analysis of national and international guidance for community clinicians referring patients with suspected chronic limb-threatening ischaemia.对国内外指导社区临床医生转介疑似慢性肢体威胁性缺血患者的文献进行分析。
BMJ Open Qual. 2024 May 20;13(2):e002784. doi: 10.1136/bmjoq-2024-002784.
3
Understanding delays in chronic limb-threatening ischaemia care: Application of the theoretical domains framework to identify factors affecting primary care clinicians' referral behaviours.
理解慢性肢体威胁性缺血性疾病治疗延误:应用理论领域框架识别影响初级保健临床医生转诊行为的因素。
J Foot Ankle Res. 2024 Jun;17(2):e12015. doi: 10.1002/jfa2.12015.
4
The symptom to assessment pathway for suspected chronic limb-threatening ischaemia (CLTI) affects quality of care: a process mapping exercise.疑似慢性肢体威胁性缺血(CLTI)的症状评估途径影响护理质量:一个流程映射练习。
BMJ Open Qual. 2024 Jan 24;13(1):e002605. doi: 10.1136/bmjoq-2023-002605.
5
Time trends and geographical variation in major lower limb amputation related to peripheral arterial disease in England.英格兰外周动脉疾病相关主要下肢截肢的时间趋势和地域差异。
BJS Open. 2024 Jan 3;8(1). doi: 10.1093/bjsopen/zrad140.
6
Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer.有既往癌症史的英国生物库参与者的心血管事件和影像学表型。
Heart. 2023 Jun 14;109(13):1007-1015. doi: 10.1136/heartjnl-2022-321888.
7
Completeness, agreement, and representativeness of ethnicity recording in the United Kingdom's Clinical Practice Research Datalink (CPRD) and linked Hospital Episode Statistics (HES).英国临床实践研究数据链(CPRD)和相关的医院入院统计(HES)中种族记录的完整性、一致性和代表性。
Popul Health Metr. 2023 Mar 14;21(1):3. doi: 10.1186/s12963-023-00302-0.
8
Are major lower extremity amputations well recorded in primary care electronic health records?: Insights from primary care electronic health records in England.主要下肢截肢术在初级保健电子健康记录中记录良好吗?:来自英国初级保健电子健康记录的见解。
Prim Health Care Res Dev. 2022 Nov 28;23:e77. doi: 10.1017/S1463423622000718.
9
Understanding variations in reported epidemiology of major lower extremity amputation in the UK: a systematic review.理解英国主要下肢截肢流行病学报告中的变化:系统评价。
BMJ Open. 2021 Oct 6;11(10):e053599. doi: 10.1136/bmjopen-2021-053599.
10
Associations between attainment of incentivized primary care indicators and incident lower limb amputation among those with type 2 diabetes: a population-based historical cohort study.激励性初级保健指标的实现与 2 型糖尿病患者下肢截肢事件的相关性:基于人群的历史队列研究。
BMJ Open Diabetes Res Care. 2021 Apr;9(1). doi: 10.1136/bmjdrc-2020-002069.